Genomictree Inc. (KOSDAQ:228760)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,180
-110 (-0.97%)
Sep 1, 2026, 3:30 PM KST

Genomictree Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-9,027-8,986-10,242-8,756-6,631-11,425
Depreciation & Amortization
1,1851,0651,1861,1781,3351,022
Loss (Gain) From Sale of Assets
385.1117.474.46--8.5-17.1
Asset Writedown & Restructuring Costs
2.267.96----
Loss (Gain) From Sale of Investments
332.18649.36-828.71328.332,0972,072
Stock-Based Compensation
754.64991.551,9341,633249.51694.04
Provision & Write-off of Bad Debts
45.9445.9445.94188.532,064-
Other Operating Activities
-1,917-2,545-2,937-3,9097,075764.11
Change in Accounts Receivable
-582.79-63.7659.14-6,688-636.9-1,362
Change in Inventory
-18.1583.08199.8554.74-303.821,000
Change in Accounts Payable
-23.32100.13,501154.42-728.24
Change in Unearned Revenue
-0.0810.27-9.17-313.19
Change in Other Net Operating Assets
-1,685-1,569-3,0551,597-1,106335.58
Operating Cash Flow
-10,547-10,193-13,633-10,8814,286-7,631
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,860-2,726-2,484-239.08-1,762-10,963
Sale of Property, Plant & Equipment
3,80042.671-21.3652.89
Sale (Purchase) of Intangibles
-129.71-19.36-67.88-49.32-61.64-865.31
Investment in Securities
1,545-393.68-11,9415,52213,459-41,774
Other Investing Activities
1,6403,1113,0042,8852,4124,478
Investing Cash Flow
4,99514.08-11,4888,11914,069-49,072

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----50,191
Long-Term Debt Repaid
--49.91-49.91-54.3-14,534-2,242
Total Debt Repaid
-56.21-49.91-49.91-54.3-14,534-2,242
Net Debt Issued (Repaid)
-56.21-49.91-49.91-54.3-14,53447,949
Issuance of Common Stock
112.15231.96---4,996
Repurchase of Common Stock
-----4,984-
Other Financing Activities
5,457-06,072-20,443-6.210
Financing Cash Flow
5,513182.056,022-20,497-19,52562,869

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
209.79-39.09102402.282,2803,654
Miscellaneous Cash Flow Adjustments
-0-----
Net Cash Flow
169.83-10,036-18,998-22,8561,1109,820

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-12,407-12,919-16,118-11,1202,523-18,593
Free Cash Flow Growth
------
Free Cash Flow Margin
-421.10%-343.58%-682.29%-325.32%8.45%-361.76%
Free Cash Flow Per Share
-512.91-538.10-675.09-419.50120.20-900.62
Levered Free Cash Flow
-9,251-8,926-10,093-29,38120,761-22,739
Unlevered Free Cash Flow
-9,095-8,715-9,909-28,09724,125-19,860

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----45.45
Cash Income Tax Paid
--40.4-129.05-73.912,096473.01
Change in Working Capital
-2,309-1,539-2,795-1,544-1,895-741.02